BioAmber Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2016. For the quarter, the company’s product sales were $1,458,000 against $367,000 a year ago. The increase in revenue was driven by volume growth in product sales. Operating loss was $8,507,000 against $8,460,000 a year ago. Loss before income taxes was $12,530,000 against $9,075,000 a year ago. Net loss attributable to the company shareholders was $10,946,000 or $0.39 per basic share against $8,398,000 or $0.38 per basic share a year ago. Net cash used in operating activities was $20,284,000 against $5,923,000 a year ago. Acquisition of property and equipment was $26,000 against $29,056,000 a year ago. Adjusted net loss attributable to the company shareholders was $8,112,000 or $0.29 per basic share against $8,578,000 or $0.39 per basic share a year ago.